6:24 PM
 | 
Jul 11, 2007
 |  BC Extra  |  Company News

FDA panel to discuss Isentress for HIV-1

FDA's Antiviral Drugs Advisory Committee will meet on Sept. 5 to discuss an NDA from...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >